Cargando…
Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice
Vincristine is an anticancer drug used to treat a variety of cancer types, but it frequently causes peripheral neuropathy. Neuropathic pain is often associated with the appearance of abnormal sensory signs, such as allodynia. Milnacipran and duloxetine, serotonin/noradrenaline reuptake inhibitors, h...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893398/ https://www.ncbi.nlm.nih.gov/pubmed/27335884 http://dx.doi.org/10.1155/2014/915464 |
_version_ | 1782435547316224000 |
---|---|
author | Katsuyama, Soh Aso, Hiromu Otowa, Akira Yagi, Tomomi Kishikawa, Yukinaga Komatsu, Takaaki Sakurada, Tsukasa Nakamura, Hitoshi |
author_facet | Katsuyama, Soh Aso, Hiromu Otowa, Akira Yagi, Tomomi Kishikawa, Yukinaga Komatsu, Takaaki Sakurada, Tsukasa Nakamura, Hitoshi |
author_sort | Katsuyama, Soh |
collection | PubMed |
description | Vincristine is an anticancer drug used to treat a variety of cancer types, but it frequently causes peripheral neuropathy. Neuropathic pain is often associated with the appearance of abnormal sensory signs, such as allodynia. Milnacipran and duloxetine, serotonin/noradrenaline reuptake inhibitors, have shown efficacy against several chronic pain syndromes. In this study, we investigated the attenuation of vincristine-induced mechanical allodynia in mice by milnacipran and duloxetine. To induce peripheral neuropathy, vincristine was administered once per day (0.1 mg/kg, intraperitoneally (i.p.)) for 7 days. Mechanical allodynia was evaluated by measuring the withdrawal response to stimulation with a von Frey filament. In vincristine-treated mice, mechanical allodynia was observed on days 3–28 of vincristine administration. A single administration of milnacipran (40 mg/kg, i.p.) or duloxetine (20 mg/kg, i.p.) had no effect on vincristine-induced mechanical allodynia. However, repeated administration of milnacipran (20 or 40 mg/kg, once per day, i.p.) or duloxetine (5, 10, or 20 mg/kg, once per day, i.p.) for 7 days significantly reduced vincristine-induced mechanical allodynia. These results suggest that chronic vincristine administration induces mechanical allodynia, and that repeated milnacipran and duloxetine administration may be an effective approach for the treatment of neuropathic pain caused by vincristine treatment for cancer. |
format | Online Article Text |
id | pubmed-4893398 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-48933982016-06-22 Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice Katsuyama, Soh Aso, Hiromu Otowa, Akira Yagi, Tomomi Kishikawa, Yukinaga Komatsu, Takaaki Sakurada, Tsukasa Nakamura, Hitoshi ISRN Pain Research Article Vincristine is an anticancer drug used to treat a variety of cancer types, but it frequently causes peripheral neuropathy. Neuropathic pain is often associated with the appearance of abnormal sensory signs, such as allodynia. Milnacipran and duloxetine, serotonin/noradrenaline reuptake inhibitors, have shown efficacy against several chronic pain syndromes. In this study, we investigated the attenuation of vincristine-induced mechanical allodynia in mice by milnacipran and duloxetine. To induce peripheral neuropathy, vincristine was administered once per day (0.1 mg/kg, intraperitoneally (i.p.)) for 7 days. Mechanical allodynia was evaluated by measuring the withdrawal response to stimulation with a von Frey filament. In vincristine-treated mice, mechanical allodynia was observed on days 3–28 of vincristine administration. A single administration of milnacipran (40 mg/kg, i.p.) or duloxetine (20 mg/kg, i.p.) had no effect on vincristine-induced mechanical allodynia. However, repeated administration of milnacipran (20 or 40 mg/kg, once per day, i.p.) or duloxetine (5, 10, or 20 mg/kg, once per day, i.p.) for 7 days significantly reduced vincristine-induced mechanical allodynia. These results suggest that chronic vincristine administration induces mechanical allodynia, and that repeated milnacipran and duloxetine administration may be an effective approach for the treatment of neuropathic pain caused by vincristine treatment for cancer. Hindawi Publishing Corporation 2014-02-23 /pmc/articles/PMC4893398/ /pubmed/27335884 http://dx.doi.org/10.1155/2014/915464 Text en Copyright © 2014 Soh Katsuyama et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Katsuyama, Soh Aso, Hiromu Otowa, Akira Yagi, Tomomi Kishikawa, Yukinaga Komatsu, Takaaki Sakurada, Tsukasa Nakamura, Hitoshi Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice |
title | Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice |
title_full | Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice |
title_fullStr | Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice |
title_full_unstemmed | Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice |
title_short | Antinociceptive Effects of the Serotonin and Noradrenaline Reuptake Inhibitors Milnacipran and Duloxetine on Vincristine-Induced Neuropathic Pain Model in Mice |
title_sort | antinociceptive effects of the serotonin and noradrenaline reuptake inhibitors milnacipran and duloxetine on vincristine-induced neuropathic pain model in mice |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893398/ https://www.ncbi.nlm.nih.gov/pubmed/27335884 http://dx.doi.org/10.1155/2014/915464 |
work_keys_str_mv | AT katsuyamasoh antinociceptiveeffectsoftheserotoninandnoradrenalinereuptakeinhibitorsmilnacipranandduloxetineonvincristineinducedneuropathicpainmodelinmice AT asohiromu antinociceptiveeffectsoftheserotoninandnoradrenalinereuptakeinhibitorsmilnacipranandduloxetineonvincristineinducedneuropathicpainmodelinmice AT otowaakira antinociceptiveeffectsoftheserotoninandnoradrenalinereuptakeinhibitorsmilnacipranandduloxetineonvincristineinducedneuropathicpainmodelinmice AT yagitomomi antinociceptiveeffectsoftheserotoninandnoradrenalinereuptakeinhibitorsmilnacipranandduloxetineonvincristineinducedneuropathicpainmodelinmice AT kishikawayukinaga antinociceptiveeffectsoftheserotoninandnoradrenalinereuptakeinhibitorsmilnacipranandduloxetineonvincristineinducedneuropathicpainmodelinmice AT komatsutakaaki antinociceptiveeffectsoftheserotoninandnoradrenalinereuptakeinhibitorsmilnacipranandduloxetineonvincristineinducedneuropathicpainmodelinmice AT sakuradatsukasa antinociceptiveeffectsoftheserotoninandnoradrenalinereuptakeinhibitorsmilnacipranandduloxetineonvincristineinducedneuropathicpainmodelinmice AT nakamurahitoshi antinociceptiveeffectsoftheserotoninandnoradrenalinereuptakeinhibitorsmilnacipranandduloxetineonvincristineinducedneuropathicpainmodelinmice |